Australia Mammography Market Size

Australia Mammography Market Analysis

The Australia Mammography Market size is estimated at USD 69.28 million in 2024, and is expected to reach USD 107.93 million by 2029, growing at a CAGR of 9.27% during the forecast period (2024-2029).

COVID-19 has affected the market studied in Australia significantly. As per the data published in December 2020 by the Australian Institute of Health and Welfare (AIHW), during the first wave of coronavirus infection, screening procedures were postponed in the country. Because of the suspension of breast screening services from March 2020, the cancer screening tests plummeted in the country. However, post lifting the nationwide lockdown in late April and early May 2020, breast screening procedures were recommenced with precautionary measures and longer appointments. On the other hand, the restarting of services was majorly impacted by several jurisdictional infection control guidelines and social distancing requirements. This practice further delayed the rescheduling of appointments for mammograms in women. Considering the urgency of cancer screening tests, the Australian government significantly undertook measures for resuming the procedures to pre-pandemic levels. The alarming decline in the number of breast screenings from January to June forced the healthcare authorities To consider mammograms as important as other healthcare practices. Thus, several breast screening services remained open during the second wave of the pandemic across Victoria. As a result, the breast screening procedures saw an upsurge from July 2020, which may impact the market growth in coming years.

The major factors affecting the growth of the market include the rising incidence of breast cancer, huge R&D in breast cancer therapies, and advances in breast imaging modalities. In August 2021, the National Breast Cancer Foundation (NBCF) and the University of Sydney announced that they would co-invest AUD 5 million in the first 10-Year Chair in Breast Cancer Prevention organized by NBCF. The major focus of the investment would be planning to implement a large-scale breast screening trial using 3D mammography. There is a surge in informative programs and initiatives undertaken by numerous organizations within the country to promote breast cancer awareness among Australian women, and collaborative efforts by the government and non-profit organizations to reduce the breast cancer burden on society. For instance, every October, the 'Not In My Family' mass media campaign is launched by BreastScreen NSW (New South Wales, Australia). The major focus of the campaign is to increase breast screening participation rates in New South Wales (NSW), Australia. Breast cancer management strategies in the country involve contributions from a wide range of government, non-governmental organizations (NGOs), and private institutions.

Therefore, with the above-mentioned factors, the mammography market in Australia is expected to witness strong growth over the forecast period.